甲氨蝶呤动脉灌注及子宫动脉栓塞联合清宫术对Ⅰ型剖宫产术后剖宫产瘢痕部位妊娠患者子宫动脉血流动力学、卵巢功能及血清SCC-Ag、SFlt-1和Ki-67的影响

迪力夏提·依明; 买买提明·马合木提; 马海鸿; 米娜瓦尔·艾麦提; 阿布都热苏力·吐尔孙; 吾热丽卡·艾力

doi:10.14009/j.issn.1672-2124.2020.12.013

您当前的位置：

首页 >

文章列表页 >

甲氨蝶呤动脉灌注及子宫动脉栓塞联合清宫术对Ⅰ型剖宫产术后剖宫产瘢痕部位妊娠患者子宫动脉血流动力学、卵巢功能及血清SCC-Ag、SFlt-1和Ki-67的影响

论著 | 更新时间：2022-10-08

- 甲氨蝶呤动脉灌注及子宫动脉栓塞联合清宫术对Ⅰ型剖宫产术后剖宫产瘢痕部位妊娠患者子宫动脉血流动力学、卵巢功能及血清SCC-Ag、SFlt-1和Ki-67的影响
- Effects of Curettage Combined with Arterial Perfusion of Methotrexate and Uterine Artery Embolization on the Hemodynamics,Ovarian Function and Serum SCC-Ag,sFlt-1 and Ki-67 in Patients with Cesarean Scar Pregnancy After Type Ⅰ Cesarean Section
- 中国医院用药评价与分析 2020年20卷第12期页码：1456-1459
- 作者机构：
  
  1. 喀什地区第二人民医院影像科
  2. 喀什地区第二人民医院产科
- 作者简介：
- 基金信息：
  
  喀什地区应用技术研究与开发计划项目（No.KS2019045）
- DOI：10.14009/j.issn.1672-2124.2020.12.013
  中图分类号： R713.8
- 纸质出版日期：2020，
扫描看全文
[1]迪力夏提·依明,买买提明·马合木提,马海鸿,米娜瓦尔·艾麦提,阿布都热苏力·吐尔孙,吾热丽卡·艾力.甲氨蝶呤动脉灌注及子宫动脉栓塞联合清宫术对Ⅰ型剖宫产术后剖宫产瘢痕部位妊娠患者子宫动脉血流动力学、卵巢功能及血清SCC-Ag、SFlt-1和Ki-67的影响[J].中国医院用药评价与分析,2020,20(12):1456-1459+1464.

Dilichati YIMING, Maimaitiming MAHEMUTI, MA Haihong, et al. Effects of Curettage Combined with Arterial Perfusion of Methotrexate and Uterine Artery Embolization on the Hemodynamics,Ovarian Function and Serum SCC-Ag,sFlt-1 and Ki-67 in Patients with Cesarean Scar Pregnancy After Type Ⅰ Cesarean Section[J]. 2020,20(12):1456-1459.
[1]迪力夏提·依明,买买提明·马合木提,马海鸿,米娜瓦尔·艾麦提,阿布都热苏力·吐尔孙,吾热丽卡·艾力.甲氨蝶呤动脉灌注及子宫动脉栓塞联合清宫术对Ⅰ型剖宫产术后剖宫产瘢痕部位妊娠患者子宫动脉血流动力学、卵巢功能及血清SCC-Ag、SFlt-1和Ki-67的影响[J].中国医院用药评价与分析,2020,20(12):1456-1459+1464. DOI： 10.14009/j.issn.1672-2124.2020.12.013.

Dilichati YIMING, Maimaitiming MAHEMUTI, MA Haihong, et al. Effects of Curettage Combined with Arterial Perfusion of Methotrexate and Uterine Artery Embolization on the Hemodynamics,Ovarian Function and Serum SCC-Ag,sFlt-1 and Ki-67 in Patients with Cesarean Scar Pregnancy After Type Ⅰ Cesarean Section[J]. 2020,20(12):1456-1459. DOI： 10.14009/j.issn.1672-2124.2020.12.013.

摘要

目的:探讨甲氨蝶呤动脉灌注及子宫动脉栓塞联合清宫术对Ⅰ型剖宫产术后剖宫产瘢痕部位妊娠（cesarean scarpregnancy

CSP）患者子宫动脉血流动力学、卵巢功能及血清鳞状细胞癌抗原（SCC-Ag）、可溶性血管内皮生长因子受体1（sFlt-1）和细胞增殖抗原-67（Ki-67）的影响。方法:将2016年9月至2019年1月于喀什地区第二人民医院接受治疗的70例Ⅰ型剖宫产术后CSP患者纳为研究对象

根据治疗方式的差异

将患者分为观察组（甲氨蝶呤动脉灌注+子宫动脉栓塞+清宫术

n=35）与对照组（开腹手术+常规治疗

n=35）。观察两组患者术后恢复情况

治疗前后血流动力学指标、卵巢内分泌功能及血清SCC-Ag、SFlt-1和Ki-67水平变化情况。结果:观察组患者术中出血量明显少于对照组

月经恢复时间明显短于对照组

β-人绒毛膜促性腺激素水平恢复时间明显短于对照组

差异均有统计学意义（P

0.05）。治疗后

观察组患者各血流动力学指标（血流搏动指数、阻力指数）水平、卵巢各激素（黄体生成素、卵泡刺激素和雌激素）分泌水平明显高于对照组

血清SCC-Ag、SFlt-1和Ki-67水平明显低于对照组

差异均有统计学意义（P

0.05）。观察组患者的并发症发生率为8.57%（3/35）

明显低于对照组的28.57%（10/35）

差异有统计学意义（χ

=4.629

P=0.031）。结论:甲氨蝶呤动脉灌注及子宫动脉栓塞联合清宫术治疗Ⅰ型剖宫产术后CSP的疗效显著

可以有效提高患者的临床疗效

促进患者病情康复

降低不良反应发生率。

Abstract

OBJECTIVE:To probe into the effects of curettage combined with arterial perfusion of methotrexate and uterine artery embolization on the hemodynamics

ovarian function and serum squamous-cell carcinoma antigen（SCC-Ag）

soluble vascular endothelial growth factor 1（sFlt-1） and cell proliferation antigen-67（Ki-67） in patients with cesarean scar pregnancy（CSP） after type I cesarean section.METHODS:Totally 70 patients with CSP after typeⅠ cesarean section admitted into the Kashgar Prefecture Second People ’s Hospital from Sept.2016 to Jan.2019 were selected and divided into observation group（treated with arterial perfusion of methotrexate+uterine artery embolization+curettage

35 cases） and control group（laparotomy+conventional therapy

35 cases） according to different therapeutic regimens.The postoperative recovery

changes of hemodynamic indicators

ovarian endocrine function and serum SCCAg

SFlt-1 and Ki-67 of the two groups before and after treatment were observed.RESULTS:The intraoperative blood loss of observation group was significantly less than that of the control group

the recovery time of menstruation and β-human chorionic gonadotropin of observation group were significantly shorter than those of the control group

with statistically significant differences（P

0.05）.After treatment

the hemodynamic indicators（PI and RI） and various ovarian hormone（LH

FSH and E

） secretion levels of observation group were significantly higher than those of the control group

while the serum SCC-Ag

sFlt-1 and Ki-67 levels were significantly lower than those of the control group

with statistically significant differences（P

0.05）.The incidence of complications of observation group was8.57%（3/35）

which was significantly lower than that of the control group（28.57%

10/35）

with statistically significant differences（χ

=4.629

P=0.031）.CONCLUSIONS:The efficacy of curettage combined with arterial perfusion of methotrexate and uterine artery embolization in the treatment of CSP after type I cesarean section is remarkable

which can significantly improve the clinical efficacy

promote patients’recovery and reduce the incidence of adverse drug reactions.

关键词

甲氨蝶呤子宫动脉栓塞清宫术Ⅰ型剖宫产术后剖宫产瘢痕部位妊娠疗效

Keywords

MethotrexateUterine artery embolizationCurettageAfter type Ⅰ cesarean sectionCesarean scar pregnancyEfficacy

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

桂枝芍药知母汤联合甲氨蝶呤治疗活动期类风湿关节炎的疗效及影响因素分析

万古霉素治疗耐甲氧西林金黄色葡萄球菌感染的血药谷浓度监测及疗效探讨

槐杞黄颗粒辅助治疗狼疮性肾炎的疗效及对患者血清铁蛋白的影响

程序性死亡受体1抑制剂一线治疗晚期非小细胞肺癌的预后及安全性

甲磺酸阿帕替尼联合依托泊苷治疗铂耐药复发卵巢癌的疗效及安全性